- By ICR Secretariat
- Posted Monday, August 3, 2020
Sanofi/GSK sign deal with UK gov for COVID-19 vaccine
Sanofi and GSK have reached an agreement with the UK government for the supply of up to 60 million doses of their COVID-19 vaccine.
The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK’s established pandemic adjuvant technology